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Introduction
Wallerian degeneration (WD) is the sequence of axonal and myelin degradation which results from mechanical or metabolic damage to the nerve. The first abnormalities occur 12 hours after injury and become more evident 24-48 hours later 1, 2 . Following degeneration of the axon, the myelin sheath collapses and initially remains within the parent Schwann cell cytoplasm. The endoneurial macrophages proliferate, become activated and initiate myelin phagocytosis 3 . This population is later supplemented by monocytes/macrophages recruited from the blood stream that participate in myelin phagocytosis and removal 4 .
Although the histology of WD is well established 5 , the molecular basis is not fully understood. We have recently shown that proteins of the complement system are produced in the undamaged PNS and are activated upon injury and disease 6 .
The complement (C) system is part of the innate immune response against pathogens. It is activated via three distinct routes: the classical, the lectin and the alternative pathways. The classical pathway is activated by the binding of C1q to non-self epitopes, either directly or via antibodies, and it is blocked by the complement regulator C1INH 7 . The lectin pathway is triggered by binding of mannose binding lectin (MBL) to certain carbohydrates on the pathogen surface 8 whereas the alternative pathway starts by spontaneous low-rate hydrolysis of C3 which binds to activated factor B on a surface lacking complement inhibitors, such as factor H. Irrespective of the initial recognition pathway, all three routes converge in the cleavage of C3 and subsequently of C5. This results in the formation of chemoattractants, opsonins and C5b, which serves as an anchor for the assembly of C6, C7, C8 and C9. The complex C5b-9, also known as membrane attack complex (MAC), is inserted into the pathogen's cell membrane, leading to cell lysis 9 .
Previous studies of WD showed that the complement system mediates myelin phagocytosis by macrophages 10 while depletion of C3 11 or C5 deficiency 12 delay WD and inhibit macrophage recruitment. However, because of their multiple functions, depletion of C3 or C5 could affect different pathways. Whether C cleaved products alone or the entire complement cascade including the MAC is needed for WD is still being debated 13 . The C6 deficient (C6 -/-) PVG/c-rat model [14] [15] [16] offers the opportunity to dissect the role of the terminal complement factors, separating the chemoattractant effect of upstream complement components from the cytolytic effect of the terminal MAC.
We analyzed the role of C6 and thus of MAC, in WD. This is relevant to the understanding of the complement-mediated events in axon loss and subsequent myelin degradation which are common hallmarks of many neurodegenerative diseases and peripheral neuropathies 17 .
Materials & Methods
Animals. This study was approved by the Academic Medical Center Animal Ethics Committee and complies with the guidelines for the care of experimental animals.
Male 12 weeks old PVG/c (wildtype, WT) were obtained from Harlan (UK) and PVG/c -(C6 -/-) rats were bred in our facility. The animals weighed between 200 g and 250 g and were allowed to acclimatize for at least two weeks before the beginning of the study. Animals were kept in the same animal facility during the entire course of the experiment and monitored for microbiological status according to the FELASA recommendations. Animals were housed in pairs in plastic cages. They were given rat chow and water ad libitum and kept at a room temperature of 20ºC on a 12 hours:12 hours light:dark cycle.
Genotyping of PVG/c-(C6 -/-) rats. The C6 -/-rats carry a deletion of 31 basepairs (bp) in the C6 gene 16 . Rat genomic DNA was prepared by proteinase K degradation of ear biopsies. Genotyping was performed by PCR (32 cycles) with annealing temperature at 60ºC, using the following forward (5'-tggctgcctgagtagaaggt-3') and reverse (5'-gtgaggtcagtaccttatcccc-3') primers. The expected size of the WT PCR product was 318 bp. As a result of a 31 bp deletion, the expected size of the C6 -/-PCR product was 287 bp.
Administration of human C6 for reconstitution studies. C6 was purified from human serum as previously described 18 . It was administered i.v. in four (4) C6 -/-rats at a dose of 4 mg/kg/day in PBS one day before the crush injury (day -1) and every 24 hours (day 0, 1, 2) until the nerves were removed at 3 days post-injury. Four (4) WT and four (4) C6 -/-rats were treated with equal volume of vehicle (PBS) alone. The C6 reconstituted rats will be indicated in the text as C6 + .
Administration of rhC1INH for inhibition studies. rhC1INH was kindly provided by Pharming (Leiden, The Netherlands). Three (3) rats were injected i.v. with one dose (500 U/kg) of rhC1INH in PBS and three (3) with vehicle (PBS) alone immediately before the crush injury. The nerves were collected after 1 hour.
Hemolytic assay. Blood samples from WT PBS-treated, C6 -/-PBS-treated and C6 -/-reconstituted with purified human C6 (C6 + ) rats were collected from the tail vein one day before the crush injury (day -1) and every day following the injury (day 1, 2, 3). All samples were collected prior to the treatment. Plasma was separated and stored at -80ºC until used to monitor C6 activity via standard complement hemolytic assay 19 .
Nerve crush injury and tissue processing. All the surgical procedures were performed aseptically under deep isoflurane anesthesia (2.5% Vol isoflurane, 1 L/min O 2 and 1L/min N 2 O). The left thigh was shaved and the sciatic nerve was exposed via an incision in the upper thigh. The nerve was crushed for three 10 s periods at the level of the sciatic notch using smooth, curved forceps (No.7). The crush site was marked by a suture which did not constrict the nerve. On the right side, sham surgery was performed which exposed the sciatic nerve but did not disturb it. A suture was also placed. The muscle and the skin were then closed with stitches. The right leg served as control. Following the crush, the rats were allowed to recover for 1hour (WT n=2; C6 -/-n=2), 4 hours (WT n=2; C6 -/-n=2), 8 hours (WT n=2; C6 -/-n=2), 12 hours (WT n=2; C6 -/-n=2), 1 day (WT n=5; C6 -/-n=5), 2 days (WT n=5; C6 -/-n=5), 3 days (WT n=5; C6 -/-n=5) and 7 days (WT n=5; C6 -/-n=5). For the C6 reconstitution study four (4) WT PBS-treated, four (4) C6 -/-PBS-treated and four (4) C6 -/-reconstituted with purified human C6 (C6 + ) rats were used. For the rhC1INH inhibition study three (3) WT PBStreated and three (3) WT C1INH-treated were used.
All the animals were intracardially perfused with 4% paraformaldehyde in piparazine-N-N´-bis (2-ethane sulphonic acid) (PIPES) buffer (pH 7.6). Left and right sciatic nerves were removed from each animal and one segment of 5mm length was collected distally from the crush site. Each segment was conventionally processed into paraffin wax for immunohistochemistry. Paraffin sections of 5 μm were cut and stained with haematoxylin and eosin (H&E) to determine tissue quality. Luxol fast blue/cresyl violet (LFB/CV) was used as a myelin stain and Palmgren's silver method to stain the axons.
Left and right tibial nerves were removed from the 1 week recovery animals, postfixed with 1% glutaraldehyde, 1% paraformaldehyde and 1% dextran (MW 20,000) in 0.1 M PIPES buffer (pH 7.6). They were divided into one proximal and one distal segment of 10 mm length. Each segment was conventionally processed into epoxy resin. Resin sections of 0.5 μm were stained with thionine and acridine orange to further assess degenerative morphological changes.
Protein extraction and Western blot analysis. Frozen sciatic nerves from 6 rats (WT n=3; C6 -/-n=3) sacrificed at 2 days following the crush injury were homogenized using a pestle and mortar in liquid nitrogen in 20 mmol l -1 Tris (pH 7.4), 5 mmol l -1 1, 4-dithio-DL-threitol (DTT) and 0.4 % SDS and 6 % glycerol. The homogenates were centrifuged at 10,000 xg, at 2 ˚C for 10 min. The supernatant fraction was collected and used for protein analysis. Protein concentrations were determined with a DC protein assay kit (Bio-Rad Laboratories, USA), using bovine serum albumin (BSA) as a standard.
Protein extracts were boiled for 5 min, separated by 7.5 % SDS-PAGE and transferred to nitrocellulose membrane overnight at 4 ºC. Prior to blotting, the nitrocellulose membranes were stained with Ponseau red for 30 sec to determine protein load. The membranes were pre-incubated in 50 mmol l -1 TrisHCl containing 0.5% Tween20 (TBST) and 5 % non-fat dried milk for 1 hour at RT. Blots were incubated for 2 hours in the primary antibody ( Table 1 ) diluted in TBST containing 5 % non-fat dried milk. Following washing in TBST, the membranes were incubated for 1 hour in horseradish peroxidase-conjugated secondary antibody diluted 1:2000 in TBST containing 5 % non-fat dried milk. Membranes were washed in TBST for 30 min and immunoreactive bands were detected using enhanced chemiluminescence (ECL, Amersham, Piscataway, NJ, USA).
Immunohistochemistry. Paraffin wax sections were stained using a three-step immunoperoxidase method. All the incubations were performed at room temperature (RT). Following deparaffination and rehydration, endogenous peroxidase activity was blocked with 1 % H 2 O 2 in methanol for 20 min. In all cases, antigen retrieval with microwave at 800 Watt for 3 min followed by 10 min at 440 Watt in 10 mM Tris/1 mM EDTA (pH 6.5) was used. To block the non-specific binding sites, slides were incubated in 10 % normal goat serum (NGS) in Tris buffer (TBS) for 20min. Following incubation in the appropriate primary antibody diluted in 1 % BSA (see table 1) for 90 min, sections were incubated for 30 min in biotinylated goat anti-rabbit or goat antimouse from DakoCytomation (Glostrup, DK) diluted 1:200 in 1 % BSA and 30 min in horseradish peroxidase labeled polystreptavidin (ABC-complex, DAKO). To visualize Polyclonal rabbit anti-cow S100 DakoCytomation 1:400
Note: * and § indicate dilutions used in the fluorescence and colorimetric immunostaining, respectively. † indicates dilution used in the Western blotting.
peroxidase activity, the slides were incubated in 0.05 % 3-amino-9-ethylcarbazole in acetate buffer (pH 5) for 5 min followed by a 30 sec counterstaining with hematoxylin and mounted in gelatin. For immunofluorescence, the primary antibody and either the secondary sheep anti-mouse Cy3 conjugated or goat anti-rabbit Fitc conjugated or rabbit anti-goat Fitc conjugated antibody from Sigma-Aldrich (Saint Louis, MI) were diluted in TBS. The slides were mounted in Vectashield mounting medium (VECTOR Burlingame, CA). Sections immunostained with secondary conjugate alone were included with every experiment as negative controls, while sections of rat spinal cord and lymph nodes served as positive controls.
Images were captured with a digital camera (Olympus, DP12, The Netherlands) attached to a fluorescent microscope (Olympus, Vanox AHBT3, The Netherlands), a light microscope (Olympus, BX41, The Netherlands) or a microscope (Zeiss, Axioplan, The Netherlands) connected to a laser scanning confocal imaging system (MRC 1024, Biorad, The Netherlands) and analyzed with analysis software (AnalySIS, Soft Imaging Systems GmbH, Zoeterwoude, The Netherlands).
CD68-, CD11b-and Pan-immunoreactive (-ir) cell count. CD68 (ED1 clone)
antibody is a lysosomal marker commonly used for macrophages but also stains other phagocytic cells. CD11b (ED7 clone) is a marker for complement 3 receptor (CR3) on activated macrophages and Pan (Ki-M2R) is a surface antigen marker of resident-like tissue macrophages. Cells were scored positive when the ED1-, ED7-or Ki-M2R-positive signal was associated with nuclei. Three to five (3-5) non-consecutive sections of rat sciatic nerve per animal were examined for each of the 3 series of immunostained slides. Each series included 4 groups (0, 1, 2 and 3 days) and 5 or 4 animals for each rat type (WT, C6 -/-, C6 + , PBS) per group. An average of 3 non-overlapping fields of view including >90% of the entire nerve area was taken for each section examined. Cell number is expressed per mm 2 .
Electron microscopy. Electron microscopy was performed on ultrathin sections of the tibial nerve from WT and C6 -/-rats at 7 days following the crush injury. Sections were contrasted with uranyl acetate and lead citrate as previously described 20 . Images were captured with a digital camera attached to an electron microscope (FEO 10, Philips, The Netherlands).
Statistical analysis.
Two way ANOVA with Bonferroni correction was performed to determine statistically significant differences in the hemolytic assay (p<0.001) and in the CD68-, CD11b-and Pan-ir cell count (p<0.05).
Results
Characterization of wildtype (WT), C6 deficient (C6 -/-) and C6 reconstituted (C6 + ) PVG/c rats. PVG/c WT rats were obtained from Harlan (UK) and C6 -/-rats were bred in our facility. Their C6 status was confirmed by genotyping analysis and standard complement hemolytic assay (CH50). Since C6 -/-rats have a 31 bp deletion in exon 10 16 , primers flanking the deletion site were designed for genotyping analysis by PCR using genomic DNA isolated from the rat ears. As expected, the PCR product from C6 -/-rats (287 bp) is smaller than that of WT rats (318 bp) (Supplementary figure  1, online) .
Plasma hemolytic activity (CH50) of WT, C6 -/-and C6 + rats was monitored over the entire course of the experiment. WT rats had an average basal CH50 of 96.3±7.3 (day -1) which did not change significantly following PBS treatment (89.4±7.5 day 1; 89.5±6.2 day 2; 86.1±5.6 day 3). C6 -/-rats had an average basal CH50 of 12.6±0.6 (day -1) and remained at control levels following PBS treatment (12.8±1.6 day 1; 13.8±2.7 day 2; 14.2±1.9 day 3). To reconstitute C6 activity in C6 -/-rats, C6 was purified from fresh frozen human plasma by affinity chromatography. It was administered in vivo by repeated i.v. injections at a dose of 4mg/kg/day. Hemolytic activity of C6 -/-rat plasma increased to 40% of that of WT rats, from a basal CH50 of 15.1±2.6 to 39.1±4.3 at 4 days from the start of the treatment (Figure 1) . (4) C6 deficiency protects from rapid WD after acute nerve trauma. To determine the role of C6 in Wallerian degeneration (WD), we performed a crush injury of the sciatic nerve in WT, C6 -/-and C6 + rats. WD of the sciatic nerve after injury was monitored on paraffin sections by immunohistochemical analysis with antibodies which recognize phosphorylated neurofilament (SMI31 clone) and myelin basic protein (MBP) and by histological analysis with Palmgren's silver staining and LFB/CV. Semithin sections of tibial nerves were also analyzed.
In the WT nerves, SMI31 immunostaining showed axonal swelling and degradation at 2 days post-injury (not shown) and it was more evident after 3 days. However, the C6 -/-nerves showed well preserved axons at 3 days post-crush (Figure 2 A) . MBP immunostaining revealed signs of myelin breakdown in WT nerves at 2 days following the injury and complete degradation after 3 days. However, the C6 -/-nerves showed myelin morphology comparable to that of control nerves at 3 days post-crush (Figure  2 B ). Histological analysis with Palmgren's silver staining and LFB/CV confirmed the results obtained with the immunohistological assay (not shown). Both WT and C6 -/-rats treated with vehicle only served as controls. Their histology did not differ from the untreated rats (not shown). These observations suggest that C6 deficiency protects the axons and the myelin from Wallerian degeneration at 3 days post-injury. C6 reconstitution restores rapid WD after acute nerve trauma. Reconstitution of C6 -/-animals with C6 (C6 + ) resulted in rapid axonal degradation in the C6 -/-nerves. Myelin breakdown was also restored at 3 days post-injury in the C6 -/-nerves upon C6 reconstitution (Supplementary figure 2, online) . The C6 + uninjured nerve was used as control and showed intact axons and myelin (not shown). These data demonstrate that the protection of the injured nerve from WD observed in the mutant mice at 3 days post-crush is a specific effect of C6 deficiency.
WD and myelin clearance are delayed in C6 deficient animals after acute nerve trauma. Analysis of the sciatic and tibial nerves (distal from the sciatic nerve where the crush injury was performed) at 7 days post-injury showed WD in both WT and C6 -/-nerves, demonstrating that Wallerian degeneration has a delayed onset in C6 -/-nerves following the crush injury. As a result of delayed degeneration, more thionine stained myelin debris was present in the C6 -/-than in WT nerves (Figure 3 A) . Electron microscopy revealed complex lipids still present in the C6 -/-nerves whereas signs of simple lipids dissolved by the dehydration processing are found in the WT nerves (Figure 3 B) . These data show that, subsequently to the delayed degeneration, myelin clearance is delayed in the C6 -/-nerves. The complement system is activated after acute nerve trauma. To determine the time course of complement activation after crush injury, we measured expression levels of the classical pathway complement components and monitored deposition of activated cleaved complement proteins.
Low levels of C1s, C1q and C1r immunoreactivity were detected in protein extracts of uninjured WT and C6 -/-rat nerves whereas high levels were seen at 2 days following the crush injury (Figure 4 ). Accordingly, a high level of C1s, C1q and C1r immunoreactivity was detected on sciatic nerve cross-sections from animals sacrificed at 3 days after the crush (Supplementary figure 3, online) . Immunoreactivity for C4c and C3c -the activated cleaved products of C4 and C3 -was detected in all injured nerves at 3 days post-injury ( Figure 5) . These results show that activation of C components upstream of C6 occurred also in C6 -/-rats. However, due to the degeneration of the nerve in WT and C6 + rat nerves, but not in the C6 -/-ones, direct comparisons of the amount of deposited C components on the nerve tissue is not possible. These data suggest a normal function of C proteins upstream of MAC formation in the C6 -/-rat model. C activation happened as early as 1h following the injury (not shown).
Deposition of MAC was observed in WT nerves at 12h (not shown) and up to 3 days post-injury. MAC was localized in the axonal compartment of the nerve as shown by the complete co-localization with the neurofilament staining. Additional MAC staining was present in the nerve and probably deposited on the degrading myelin sheaths (Supplementary figure 4, online) . The C6 -/-nerves were negative for MAC deposition which was restored upon C6 reconstitution (C6 + ), confirming lack of C6 in the deficient nerves and the ability of purified human C6 to reach the nerve from the circulation and be functional. Uninjured control nerves were always negative for MAC staining ( Figure 5 ). rhC1INH blocks complement activation after acute nerve trauma. To determine which complement pathway is activated following the crush injury, we treated WT rats with rhC1INH, an inhibitor of the classical pathway. Complement activation up-and down-stream of the inhibition site were monitored in rhC1INH-treated rats following the injury. Detection of dense deposits of C1q (C component up-stream of the rhC1INH target site) in the PBS-and rhC1INH-treated nerves confirmed up-regulation of the classical pathway complement components following the injury. C4c and C3c (C components downstream of the rhC1INH target site) deposition was very high in the PBS-treated nerves and completely absent in the inhibitor-treated nerves at 1 hour post-injury (Figure 6 ). This demonstrates that the classical pathway is activated and that, at least at this early time point, the alternative pathway does not contribute to the activation of the complement cascade after nerve injury.
C6 deficiency protects the nerve from macrophage accumulation and activation at 3 days post-injury. Since myelin removal in degenerating nerves mainly depends on invading, non-resident macrophages 21 we monitored macrophage recruitment and activation. Sections were analyzed with the CD68 (ED1 clone) antibody, which is used as a lysosomal marker; CD11b (ED7 clone) which detects the rat complement receptor 3 (CR3) present on activated macrophages 22 and essential for myelin phagocytosis 10, 23, 24 and Pan (Ki-M2R clone) antibody which recognizes a surface antigen on resident tissue macrophages.
A quantitative analysis (Figure 7) revealed only a few CD68-positive cells (WT 13.2±1.7; C6 -/-12.6±1.4) in the control uninjured nerves. In both, WT and C6 -/-nerves, the number of CD68-positive cells remained at control levels until 2 days post-injury when they increased to 59.4±4.2 and 49.8±11.2, respectively. At 3 days post-injury the CD68 immunoreactivity was significantly higher in the WT crushed nerves (245.8±19.6) compared to the C6 -/-ones (52.4±6.4). Upon reconstitution of the C6 -/- Figure 6 . Blockade of complement activation after rhC1INH treatment. Immunostaining for complement component C1q, upstream of the inhibition site of rhC1INH, and cleaved components C4c and C3c at 1 hour post-injury in cross-sections of sciatic nerves from WT rats treated with rhC1INH or vehicle (PBS) alone. High immunoreactivity for C1q is detected in all injured nerves, confirming C1q up-regulation after the crush injury. C4c and C3c immunoreactivity is detected in the PBS-treated nerves as expected whereas no deposition is detected in the nerves from the rhC1INH treated rats, demonstrating effective blockade of the complement cascade after crush and implicating the classical pathway in the crush injury model of Wallerian degeneration. Sections are counterstained with haematoxylin. Bar is 50μm. For color figure see page 151.
nerves with C6, the number of CD68-positive cells increased close to WT levels (191.2±9.8). Treatment of WT animals with PBS did not alter significantly the number of CD68-positive cells in the injured nerves (261.2±42.9). A morphological analysis of the CD68-immunoreactive (-ir) cells at 3 days post-injury, showed enlarged and asymmetrical cells in WT nerves while they remained small and round in the C6 -/-nerves (Figure 8 A and insets) . C6 reconstitution re-established the WT phenotype (not shown). The number of CD11b-positive cells was very low in the uninjured nerves (WT 1.2±2.5; C6 -/-0.6±1.9) but it increased in the WT nerves at 1 day (17.4±2.5) and 2 days (76.5±28.3) after injury, reaching 182.9±59.7 after 3 days. The C6 -/-nerves did not show any significant change in the number of CD11b-positive cells after injury. In the C6 + nerves, the number of CD11b-positive cells increased close to WT levels at 3 days post-injury (174.8±39.9). Treatment of WT animals with PBS did not alter significantly the number of CD11b-positive macrophages in the injured nerves (197.9±59.9). The increase in CR3 immunoreactivity demonstrates macrophage activation in the WT nerves but not in the C6 -/-nerves.
Strong immunoreactivity of CD11b was associated with large macrophages in WT, C6 + and PBS-treated nerves at 3 days post-injury. In contrast, C6 -/-nerves contained very few cells slightly positive for the CD11b macrophage marker (Figure 8 B) . The low CR3 staining is not an inherent property of C6 -/-rats because lymph nodes of C6 -/-rats contained cells which were strongly positive for CD11b (Supplementary figure 5,  online) .
The Pan macrophage marker showed a few positive cells (WT 10.6±4.4; C6 -/-11.2±4.0) in the uninjured nerves. In both WT and C6 -/-nerves the number of Pan-positive cells remained at control levels until 2 days post-injury when they increased to 95.2±17.0 and 92.1±20.2, respectively. At 3 days post-injury the number of Pan-positive cells did not change in the C6 -/-nerves whereas it dropped to 11.2±7.9 in the WT nerves, demonstrating that macrophages lose the resident-like phenotype in the WT nerves but this is still maintained by the macrophages in the C6 -/-nerves. Both the C6 + and PBS-treated nerves showed similar Pan immunoreactivity as the WT nerves (C6 + 3.7±7.9; PBS 6.8±11.2). Pan-ir cells were generally very small, a morphology typical of macrophages who retain the resident-like phenotype (Figure 8 C) .
Confocal images of double immunofluorescent staining of CD68 and MBP demonstrated the presence of myelin debris in the enlarged CD68 positive cells in WT and C6 + nerves at 3 days post-injury (Figure 8 D, inset) , demonstrating active myelin phagocytosis by the CD68-ir cells. This data demonstrates that C6 deficiency prevents macrophages accumulation and activation in the WT nerve at 3 days post injury.
Analysis of phagocytic cells at 7 days post-injury.
There was no significant difference in the number of CD68-ir cells between WT (189.28±40.6) and C6 -/-(171.1±29.4) nerves at 7 days post-injury and in both strains they contained myelin debris as showed by their co-localization with MBP (Figure 9 A) . However in the WT nerve, CD68-ir cells were also CD11b positive, suggesting that they were macrophages. In the C6 -/-nerve, CD68-ir cells were negative for CD11b (not shown). Since there is evidence that proliferating Schwann cells contribute to myelin degradation 4 , we stained the nerve sections with S100, a Schwann cell marker, and co-localized it with the CD68 antibody. Virtually all CD68-ir cells in the C6 -/-nerves were S100 positive (Figure 9 B) whereas only a minority of the CD68 cells were S100 positive in the WT nerves. These results demonstrate that, although cells containing myelin debris were present in both strains at 7 days post-injury, they differ in nature. and CD68 (orange) of rat sciatic nerve at 7 days following the crush injury, showing higher density of myelin debris in the C6 -/-nerve compared to the WT nerve whereas the number of CD68-ir cells is similar in both nerves. Note the vacuolated morphology of CD68-ir cells in the WT nerve, typical of foamy macrophages. The merged images show co-localization of MBP and CD68 staining in both nerves (yellow and inset). (B) Double immunofluorescent staining for S100 (green) and CD68 (orange) of rat sciatic nerve at 7 days following the crush injury, showing complete co-localization (yellow) in the C6 -/-nerve (arrows→ and inset) whereas in the WT only a few CD68-ir cells are also S100 positive. Note the higher S100 immunoreactivity in the C6 -/-nerve compared to the WT. Nuclei staining with DAPI (blue) is included in the merged images. Bar is 50μm. For color figure see page 153.
Discussion
This study shows that formation of the membrane attack complex (MAC) is necessary for rapid Wallerian degeneration (WD). Signs of WD were already detected in the WT nerves at 2 days following the injury, with extensive axonal and myelin degeneration after 3 days. This is consistent with the well documented observations of Waller and Ramón y Cajal 1, 5 . Interestingly, no signs of WD were detected at 3 days after the crush in the C6 -/-nerves, suggesting that the inability to form the MAC protects from early axonal and myelin degeneration after injury. Reconstitution of C6 -/-animals with C6 restored WD at 3 days post-injury, demonstrating that the difference in the early phase of WD is due to the lack of C6. WD was however not permanently blocked in the C6 -/-animals, since complete axonal and myelin degradation was observed at 7 days post-injury.
This study specifically addresses the current controversial issue on whether or not formation of the MAC is needed in the complement-mediated destruction of nervous tissue which occurs in numerous diseases of the CNS and PNS 25 . Our results demonstrate that the ability to assemble the MAC is crucial in the initial events leading to axon loss and myelin breakdown. This work supports previous studies 18, 26 who showed delayed demyelination in C6 -/-rats affected by antibody-mediated experimental autoimmune encephalomyelitis (ADEAE), a model of multiple sclerosis, and enhanced axonal injury and demyelination in ADEAE mice deficient in the MAC inhibitory regulator CD59.
Since the C6 -/-animals have normal function in the upstream members of the complement cascade, we can discriminate between the specific role of MAC and other functions of the complement proteins like opsonization and chemotaxis during WD. Deposition of the MAC occurred at multiple sites in the nerve including the axonal compartment, as demonstrated by its co-localization with the neurofilament staining. Accumulation of MAC deposits on nervous tissue can damage membranes; a devastating event for the fate of a nerve is the uncontrolled calcium influx through the MAC-derived pores 27 . Calcium activates calpains, calcium-dependent proteases which cleave cytoskeletal proteins including neurofilament, resulting in structural disorganization of the nerve. Calpain inhibitors were protective against axonal cytoskeletal loss in a model of complement-mediated motor nerve terminal injury 28 . MAC deposits have been found on damaged nerve terminal axons and surrounding perisynaptic Schwann cells in a mouse model of neuropathy and the damage was exacerbated in tissues from mice lacking CD59, where MAC formation is increased 29 . A follow-up study showed that inhibition of complement activation with APT070 blocked MAC formation and rescued axonal and perisynaptic Schwann cell integrity 30 .
Systemic treatment with recombinant human C1 inhibitor (rhC1INH) blocks the classical pathway and reduced acute damage in the treated injured nerve. However, due to its short half-life, long-term experiments were not possible. This experiment demonstrates involvement of the classical pathway of the complement system in WD after acute nerve trauma but does not exclude a later contribution of the alternative pathway.
Recruitment of macrophages is a known function of activated complement components. The analysis of macrophages in WT rat nerves before and after the injury confirmed the pattern previously described [31] [32] [33] . In the control uninjured nerve a small number of endoneurial macrophages is present. These consist of both long-term and short-term resident macrophages 34 . The slight increase in CD68-positive cells in both WT and C6 -/-nerves as early as 2 days after injury is probably due to proliferation and differentiation of the endoneurial macrophage population which still retains the resident-like (Pan-positive) phenotype but start to express the CD68 lysosomal marker. These macrophages have the potential to phagocytose myelin 3 . At this time point, in WT nerve, macrophages express high levels of the CR3 receptor which is essential for myelin phagocytosis 10, 35, 36 whereas in the C6 -/-nerves CR3 expression is virtually undetectable, consistent with the small and round morphology typical of inactive macrophages. At 3 days following the crush, the pattern of expression of all three (CD68, CD11b and Pan) macrophage markers differs between the two strains. In WT nerves, considerable increase in CD68-positive cells occurs. These cells maintain the activated (CD11b-positive) but loose the resident-like (Pan-positive) phenotype, and contain vacuoles and myelin debris within lysosomes. At 7 days post-injury, CD68 immunoreactivity is still very high in the WT nerve. Most of these cells are macrophages and still maintain the activated phenotype (CD11b-positive). At this time point, myelin is almost completely removed.
The C6 -/-rats show a different pattern of macrophage response. Following the initial (2 days) increase, no further accumulation of macrophages occurs at 3 days post-injury. Cells maintain the resident-like phenotype (Pan-positive) and no evidence of myelin activation (CD11b-immunoreactivity) or phagocytosis (MBP-CD68 co-localization) was observed, explaining the integrity of the myelin sheath. This lack of macrophage activation is dependent on C6 since reconstituting the C6 -/-animals restored the WT phenotype. Thus, a C6 dependent factor, MAC formation, and not C3 as previously suggested 11 , is essential for efficient macrophage accumulation and activation during WD. In the C6 -/-ADEAE rat model, which is protected from demyelination at least up to 14 days after disease induction, macrophages accumulate in the nerve but they fail to engulf myelin 18 .
At 7 days post-injury, the C6 -/-nerve which has degenerated by this time, shows extensive CD68 immunoreactivity. These cells are probably Schwann cells since they are positive for the Schwann cell marker S100 and negative for the CD11b and Pan macrophage markers. CD68 positive phagocytic Schwann cells have previously been described 37 and our in vitro cultured Schwann cells are also occasionally CD68 positive (data not shown). These CD68/S100 positive cells contained myelin debris suggesting that Schwann cells can digest myelin in the absence of macrophages in vivo, which is in line with the in vitro data 38 .
We propose the following model (Supplementary figure 6, online) . Following crush, C1q binds axonal and myelin epitopes exposed by the mechanical injury, activating the classical pathway. The damaged nerve is then opsonized by C4b, C3b and C5b which act as opsonins for macrophages. In the WT animals formation of MAC creates pores on the axolemma allowing influx of calcium, into the axon. This activates calpains contributing to the rapid damage of the nerve. The MAC-induced neuronal debris is also targeted by C1q creating a positive feedback loop resulting in increased opsonization and macrophage activation and recruitment, leading to rapid degeneration. In the C6 -/-rats the crush-derived debris is the only target for opsonization and not sufficient for efficient activation of macrophages to acquire the phagocytic phenotype. WD and myelin removal in the absence of C6 is carried out in a slow, opsonin-independent manner by proliferating Schwann cells.
In conclusion, we demonstrated that the classical pathway of the complement system is activated after acute nerve trauma and that the entire complement cascade, including MAC deposition, is essential for rapid WD and efficient clearance of myelin after acute nerve trauma of the PNS.
Wallerian degeneration is a process common to many injury and non-injury related disorders of the PNS and CNS 39 . It results in axon loss which is the major determinant of disability in such disorders. Understanding the mechanisms of axonal degradation could lead to new therapies aimed at delaying or preventing axon loss. Our study shows that activation of complement, specifically MAC, is responsible for the early events of axonal degradation during WD. Complement inhibition or blockade of calciumdependent proteases could protect the axon from the initial degradation.
Complement blockade 31 , calcium depletion and calpain inhibition 29 have already been shown to limit nerve terminal and axonal injury in a model of acquired peripheral neuropathy. We propose that complement inhibition could directly prevent axonal damage and indirectly inhibit macrophage accumulation in the nerve, ameliorating the disease outcome.
In some neurodegenerative diseases like multiple sclerosis, axonal damage has only recently emerged as a substantial determinant of pathology 40 . Delaying axonal degeneration could give a chance for more axons to survive a period of demyelination, arresting the decline from the relapsing-remitting to the progressive phase of the disease. Traumatic brain and spinal cord injuries are characterized by diffuse axon loss and complement activation 41 . Pathology secondary to the primary mechanical damage appears to be a major determinant of clinical outcome 42 . The secondary axonal damage occurs hours after the initial insult opening a window of opportunity for therapy aimed at rescuing the axons. Inhibition of complement activation could prevent spreading of secondary axon loss.
